Articles tagged with Cerebrospinal Fluid
A new AI-powered algorithm, M-PACT, uses liquid biopsy to classify pediatric brain tumors based on DNA methylation patterns. The technology has been shown to achieve a high sensitivity rate of 92% in identifying brain tumors.
Researchers found that certain types of CD8+ killer T cells are more abundant in people with MS and target the EBV virus, indicating the virus may trigger an immune response leading to progressive neurological damage. The study suggests that interfering with EBV could have a significant impact on other autoimmune diseases.
Researchers have developed a breakthrough light-responsive Janus dural patch using photocurable hyaluronic acid, providing strong wet adhesion and preventing unwanted tissue adhesion. The patch seals wounds within five seconds with minimal swelling and high biocompatibility.
Researchers demonstrated that 40-Hz auditory stimulation significantly elevates beta-amyloid levels in the cerebrospinal fluid of aged rhesus monkeys, with effects persisting for over five weeks. The study provides evidence supporting 40-Hz stimulation as a non-invasive therapy for Alzheimer's disease.
Researchers found that sleep-deprived individuals experience attentional failures coinciding with a flushing of CSF from the brain. During these lapses, physiological changes occur, including a flux of CSF out and then back in. The study suggests that the brain attempts to compensate for lost cleansing by initiating pulses of CSF flow.
Researchers have discovered that deep sleep plays a crucial role in controlling cerebrospinal fluid dynamics, which is essential for clearing waste from the brain. During slow-wave sleep, changes in cerebrospinal fluid signals are time-locked to slow brain waves and other neural events.
The partnership aims to accelerate the development of treatments for neurological diseases by providing a cutting-edge biorepository for pediatric CNS tissue and biofluids. The repository will house high-quality, well-characterized human tissues and bio fluids, supporting drug discovery efforts and biomarker identification.
Aging and depression are linked to complex brain-body communication, with organs aging at different rates and influencing disease susceptibility. Dr. Hamilton Oh's research reveals how immune cells and metabolic organs amplify or dampen mood symptoms, offering novel therapeutic targets.
Researchers have discovered a new method to enhance brain waste clearance by precisely stimulating the lymphatics under skin on the neck and face. This non-invasive approach may offer a safer alternative to current treatments for age-related neurological disorders, such as Alzheimer's disease.
Researchers from USC Keck School of Medicine have developed a low-cost blood test that detects five biomarkers of Alzheimer's disease, including amyloid and tau proteins. The test uses xMAP technology and has the potential to catch the disease in its earliest stages, when treatment might be able to prevent or delay cognitive decline.
Researchers at Amsterdam UMC have developed a new diagnostic test that measures CRP protein in cerebrospinal fluid to quickly diagnose bacterial meningitis. The test has been shown to be very reliable and can start treatment within half an hour of diagnosis.
A misfolded protein in spinal fluid facilitates reliable Parkinson's diagnosis even in its early stages. The biomarker has a sensitivity and specificity of over 90%, making it a promising tool for disease management and potential therapy development.
A new Concordia-developed app, iSurgARy, uses augmented reality to guide catheter insertion into the brain, improving ventriculostomy safety and accuracy. The app provides spatial awareness of patient anatomy, allowing surgeons to better aim at their target points.
Researchers have identified signs of neuroinflammation and blood-brain barrier dysfunction in patients with Down syndrome Regression Disorder (DSRD). The study, published in Annals of Clinical and Translational Neurology, reveals a potential immune-related cause for DSRD.
Researchers at Kyushu University have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs. By analyzing cerebrospinal fluid, they identified specific proteins associated with an immune response that can affect the central nervous system after therapy.
A new University of Cincinnati trial is comparing two types of omega-3 supplements, LPC-DHA and TAG-DHA, to slow or prevent dementia progression in elderly adults. Researchers aim to investigate whether LPC-DHA supplementation increases CSF DHA levels and improves cognitive function.
A new blood test has shown promise in improving the accuracy of Alzheimer's Disease diagnosis, with results comparable to established CSF biomarkers. The study found that measuring plasma p-tau217 was over 90% accurate, potentially replacing invasive diagnostic methods for up to half of patients.
Researchers developed a biomarker test that can detect small amounts of tau protein and its misfolded forms in cerebrospinal fluid, correlating with cognitive decline severity. The test identifies early stages of tau tangle formation up to a decade before brain scans, opening doors for early-stage disease diagnosis and intervention.
Researchers at Uppsala University found that Semliki Forest virus penetrates the central nervous system by entering the cerebrospinal fluid and binding to VLDLR before penetrating deeper into the brain. This finding could be used to develop the virus as an agent for treating brain cancer.
A study published in Cell describes the synchronized oscillations that occur during non-REM sleep, including norepinephrine, cerebral blood volume, and CSF flow. The research highlights the critical role of these oscillations in powering the glymphatic system, which removes protein waste associated with neurodegenerative diseases.
The study aims to identify early warning signs and potential treatment for cerebral small vessel disease, a condition linked to vascular dementia. Researchers will analyze cerebrospinal fluid and brain tissues using cutting-edge technologies to map mRNA within cells affected by the disease.
A new finger prick test for Alzheimer's disease has shown strong performance in a European study, measuring biomarkers in blood from superficial vessels. The test could soon be implemented globally, increasing accessibility to Alzheimer's testing without the need for high-sensitivity analyses.
Researchers linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The study identified 38 proteins with causal effects in Alzheimer's progression, including 15 potential targets for medicines.
A groundbreaking metagenomic sequencing test has proven effective in rapidly diagnosing almost any kind of pathogen, including viruses, bacteria, fungus or parasite. The test analyzes all nucleic acids present in a sample, replacing multiple tests with a single one and speeding up diagnosis.
A new study has definitively revealed the presence of an efficient waste-clearance system within the human brain, showing that cerebrospinal fluid flows through specific pathways to clear metabolic wastes generated by brain energy. Lifestyle measures and medications can maintain and enhance this system.
Researchers at Fujita Health University have discovered critical impairments in purine metabolism and ATP recycling in patients with Parkinson's disease. The study highlights the importance of enhancing ATP production to slow disease progression and improve quality of life.
A recent study on anaesthetic effects on cerebrospinal fluid flow and volume reveals significant findings, potentially reshaping neuroanaesthesia practices. The research found that commonly used anaesthetics blunt the vasomotor responses and cerebrospinal fluid flow effects of carbon dioxide.
Researchers successfully restored the brain's waste-clearing process by reviving cervical lymph vessel function in aging mice, utilizing a known drug to boost efficiency. This breakthrough could pave the way for future therapies targeting neurodegenerative diseases.
Researchers found that removing the choroid plexus leads to a reduction of newly born immature neurons and fewer repairing damage caused by a stroke. The study suggests that the choroid plexus keeps regenerative cells ready to deploy to injured areas in animal models.
Researchers describe how a spreading wave of disruption and brain fluid flow triggers headaches, detailing the connection between aura symptoms and migraine pain. The study identifies potential new drug targets for migraines, including proteins that bind with sensory nerves in the trigeminal ganglion.
A previously unknown mechanism in the brain causes migraine attacks by carrying proteins to specific nerve cells, explaining one-sided headaches. The discovery may lead to new treatment options and help understand other headache diseases.
Researchers have developed procedures for using gold nanostars to perform more efficient, conformal, and safe laser ablations for treating brain tumors. This technique addresses limitations in traditional LITT by providing improved precision for lesions greater than 3 cm or with complex shapes.
Researchers developed a rapid genotyping test for patients with central nervous system lesions, detecting key mutations associated with brain cancers in samples taken during a lumbar puncture. The test eliminated the need for surgical brain biopsies in seven cases and significantly accelerated time to treatment, from an average of 12 d...
UCSF scientists discover delivering therapeutic molecules to amniotic fluid can effectively treat Angelman syndrome and other neurological conditions. The treatment uses antisense oligonucleotides, which can alter gene expression, and has shown improved motor function and learning outcomes in mice.
A life-threatening mold infection known as Fusarium solani meningitis can cause devastating brainstem and blood supply injuries among healthy patients. The fungus was resistant to all antifungal agents except Fosmanogepix, leading to the development of an experimental treatment.
Researchers have identified a network of lymphatic vessels at the back of the nose as a major hub for CSF outflow to deep cervical lymph nodes. This discovery has significant implications for understanding and treating conditions related to impaired CSF drainage, such as Alzheimer's disease.
Researchers report a case of a patient with EGFR L858R mutant non-small cell lung cancer (NSCLC) who experienced durable disease improvement after empirical treatment with osimertinib. The 'Lazarus effect' refers to the phenomenon where cancer appears to recur after seeming to be in remission.
Researchers from UTHealth Houston discovered that Epstein-Barr virus (EBV)-specific T-cells are present in high numbers in the cerebrospinal fluid of people with multiple sclerosis at its earliest stages. The study suggests that these cells may be contributing to the disease's pathogenesis.
Researchers found that infants with enlarged perivascular spaces have a 2.2 times greater chance of developing autism compared to those with the same genetic risk. The study also indicates that these infants are more likely to experience sleep problems seven to ten years after diagnosis.
New research reveals a cocktail of approved drugs can quickly reduce brain swelling and improve outcomes in animal models of brain injury. The study suggests reopening lymph nodes as an emergency pressure release valve for the brain, addressing cerebral edema as the leading cause of TBI-related deaths.
A recent study by the University of Gothenburg found no correlation between post-COVID condition and ongoing viral infection or active brain damage. The study analyzed 25 participants with confirmed post-COVID condition, six without residual symptoms, and 17 control subjects, revealing undetectable SARS-CoV-2 antigens in all samples.
A new study published in Science Advances suggests that a decades-old anti-anxiety drug can improve the effectiveness of chemo-radiotherapy towards glioblastoma, the most common and lethal brain cancer. The researchers found that the drug trifluoperazine can re-sensitize tumor cells to both therapies, leading to improved patient survival.
Researchers propose that cerebrospinal fluid leaks could contribute to the link between traumatic brain injury and dementia. The hypothesis suggests that treating these leaks could mitigate dementia symptoms in some patients with a history of TBI. Further research is needed to confirm this potential association.
Scientists have detected over 300 proteins associated with lipoproteins in the central nervous system, far more than previously thought. The most common protein, apolipoprotein E (APOE), plays a key role in delivering nutrient-rich lipids and protein tools to perform tasks such as wound healing and neuron creation.
Researchers developed a molecular test to identify brain tumors by analyzing genetic material in cerebrospinal fluid. The Real-CSF test correctly identified 67% of cancerous and 96% of noncancerous brain lesions, outperforming standard cytology methods.
Researchers at Medical University of South Carolina describe a new, non-surgical approach to managing hydrocephalus by implanting a shunt-clearing device and performing daily flushing. The study shows promising results, reducing revision surgeries and improving patient outcomes.
A new biomarker, MTBR-tau243, tracks Alzheimer's disease progression by measuring levels of a specific form of tau in cerebrospinal fluid. The finding has major implications for diagnosing and staging the disease, and could accelerate the development of effective treatments.
Researchers developed a new method to deliver drugs into the inner ear, using the cerebrospinal fluid flow. This innovation restored hearing in deaf mice and may pave the way for gene therapy to treat human hearing loss.
Aneurysmal subarachnoid hemorrhage-related hydrocephalus is a complex syndrome that can lead to cognitive impairment and neurological damage. The new consensus guideline recommends standard-of-care approaches, including history review, head CT scans, and medications or surgical interventions to manage excessive intracranial pressure.
A study published in Scientific Reports found that longer spaceflight missions can cause ventricle volume expansion, which tapers off after six months. Astronauts who had shorter recovery times between missions showed little to no enlargement of their ventricles post-flight.
A study of 30 astronauts found that brain ventricles expand significantly after longer space missions, taking up to three years to fully recover. The expansion is caused by fluid shifting upward in the absence of gravity, leading to potential long-term health concerns for space travelers.
Researchers found reduced editing efficiency of GluA2 mRNA in ALS patients' cerebrospinal fluid, correlating with longer disease duration and advanced symptoms. This discovery could lead to the development of therapies targeting RNA editing for treatable ALS cases.
Researchers at Mount Sinai have discovered a previously unknown way in which the brain and immune system interact in multiple sclerosis. They found that the inflammatory protein interleukin-3 (IL-3) coordinates this communication, inciting the recruitment of immune cells to the brain and exacerbating brain inflammation.
A new study by Boston University researchers reveals that visual stimulation can induce large-scale changes in cerebrospinal fluid flow during wakefulness. The findings have implications for treating conditions like Alzheimer's disease, which are associated with declines in fluid flow.
Researchers at the University of Texas M. D. Anderson Cancer Center have developed a novel approach to administer intrathecal and intravenous immunotherapy to treat leptomeningeal disease (LMD) in melanoma patients, showing promising results in improving survival rates and quality of life for some patients.
Researchers discovered that lipid deposition on medical implant surfaces can signal to the immune system whether to attack or ignore the implant. This knowledge could help develop biomaterials that deflect host immune aggression, reducing malfunction rates for devices like pacemakers and surgical mesh.
Researchers discovered that sensory cells in the spinal cord's central canal can detect bacteria in cerebrospinal fluid and trigger an inflammatory response to fight brain infections. These 'taste' receptors recognize bitter substances, such as those from Streptococcus pneumoniae, and increase cytokine production to combat pathogens.
A recent clinical study reveals a correlation between low intracranial pressure and impaired patient visibility, especially in the nasal zone. Higher translaminar pressure difference is estimated as a risk factor for normal tension glaucoma development.
Researchers developed a new imaging technique revealing abnormal circulation patterns of brain fluid in developing brains. Disruptions to cerebrospinal fluid flow may underlie cognitive deficits and developmental delays in conditions like hydrocephalus.
Research suggests that a new combination of drugs is needed to find an effective treatment for TB meningitis due to multidrug-resistant strains. The FDA-approved BPaL regimen is not effective in treating TB meningitis because bedaquiline and linezolid cannot penetrate the blood-brain barrier.